Clearly our problem in our economy right now is unemployment, and we know that that unemployment is disproportionately focused upon blue collar workers.

At some point we have to move beyond existential fear, oh, my gosh, we don't know all the unknowns, and say if we are going to protect patient safety and we know this is an incredible problem, let us embrace the fear, if you will.

But see, the National Association of Boards of Pharmacy, the NABP, currently does that.

We are not spending, to my mind, and I am an appropriator, we are not spending the percentage of our total overall spending on research and development that your companies would.

America who has been the most successful country in the world for this entrepreneurial, democratic, open society, we would have a lot of ideas and services that help to create this country that the world is desperately in need of.

So with that said, Representative Ross and I in a companion bill to something that Senators Feinstein and Cornyn and others have introduced on the other side have an online pharmacy bill requesting that FDA compile a registry of legitimate…

That is my big, big concern here.

Until you get your private property rights done over here, you are not going to be able to do anything.

I mean, there are things we know even though we beat ourselves up and say how terrible we are, the fact is we are pretty great and we still are.

I did not vote for final passage but I did vote for the Crowdfunding piece that Scott Brown and others put forward.

The Federal Government overall is somewhere between two and three. That should be frightening to everyone.

Capital does not flow to the smartest most able, it flows to those that are most connected. Period.

Like a lot of members on the subcommittee and otherwise, I have a single, very basic, fundamental concern which is funding for all this activity really being dramatically cut and changed since the New START treaty was passed.

But they advertise via Google, and so I suspect that--I mean, it is not an impossibility to do it.

I agree that reauthorization of Ex-Im should be a relatively straightforward matter, and I think it can be if the key concerns that many folks have brought to bear in the debate are addressed directly.

Ninety-two percent of all Ex-Im transactions did not receive any adverse impact analysis--none whatsoever.

This goes to a broader management issue of Ex-Im Bank regarding the extent to which it properly looks at adverse impacts of loans it is considering.

In the President's January announcement on tourism, he said one of his goals is to expedite the visa issuance process for visitors from Brazil and China.